GRRMF (Gerresheimer AG) Research & Development: $24 Mil (TTM As of Aug. 2025)


GRRMF Gerresheimer AG GRRMF
67 GF Score
Price $32.10
GF Value $119.57
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Gerresheimer AG Research & Development?

Gerresheimer AG GRRMF 67 Research & Development is $24 Mil as of Aug. 2025. GuruFocus rates GRRMF with a GF Score™ of 67/100 and a GF Value™ of $119.57 (Possible Value Trap). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Gerresheimer AG's Research & Development for the three months ended in Aug. 2025 was $6 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Aug. 2025 was $24 Mil.

Gerresheimer AG  (OTCPK:GRRMF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Gerresheimer AG Research & Development Related Terms

Gerresheimer AG Research & Development Historical Data

* Premium members only.

The historical data trend for Gerresheimer AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gerresheimer AG Research & Development Chart

Gerresheimer AG Annual Data
Trend Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.05 11.38 22.04 17.45 23.76

Gerresheimer AG Quarterly Data
Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.26 7.32 6.37 3.56 6.48
GRRMF
67GF Score
Gerresheimer AG GRRMF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gerresheimer AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Aug. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $24 Mil mean?
Gerresheimer AG (GRRMF) has a Research & Development of $24 Mil as of Aug. 2025. Research and development expense is the total cost for research and development activities. View historical data on Gerresheimer AG and its competitors.
Is Gerresheimer AG's Research & Development too high?
Gerresheimer AG's current Research & Development is $24 Mil. Overall, Gerresheimer AG has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's Research & Development compare to ISRG and BDX?
Gerresheimer AG's Research & Development of $24 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Gerresheimer AG and its competitors. Gerresheimer AG's current Research & Development is $24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (GRRMF) is currently considered Possible Value Trap. The stock's GF Value™ is $119.57, compared to a current price of $32.10 — trading 73.2% below its estimated fair value. The current Research & Development is $24 Mil. Gerresheimer AG's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Gerresheimer AG (GRRMF), the current Research & Development is $24 Mil as of Aug. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gerresheimer AG (GRRMF) Overvalued in 2026?

Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued. The current stock price of $32.10 is trading 73.2% below its estimated GF Value™ of $119.57. GuruFocus considers Gerresheimer AG to be Possible Value Trap.

Key valuation signals for GRRMF:

  • Research & Development: $24 Mil
  • GF Value™: $119.57 vs. price of $32.10 (73.2% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the GRRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gerresheimer AG Business Description

Address Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
67GF Score

Get the complete analysis for GRRMF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$32.10
Price
$119.57
GF Value